A Respected Organization

The Scientist has in a very short time gained a reputation for informed and balanced coverage of important developments in world science. It is therefore difficult to understand why the paper should publish a misleading article on the National Science Foundation's Division of Science Resources Studies (SRS) in the July 22 issue [page 1]. The United States and international scientific communities both have much to thank SRS for in respect of its continuing role in pioneering the production of us

Written byJohn Irvine
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist has in a very short time gained a reputation for informed and balanced coverage of important developments in world science. It is therefore difficult to understand why the paper should publish a misleading article on the National Science Foundation's Division of Science Resources Studies (SRS) in the July 22 issue [page 1].

The United States and international scientific communities both have much to thank SRS for in respect of its continuing role in pioneering the production of useful R&D statistics. This said, all organizations "age," and undoubtedly there have been problems within SRS during the last 18 months.

However, it is questionable whether these problems have been caused primarily by cronyism, sexism, racism, and incompetence among time-serving SRS staff (as your coverage indicates) or by such other factors as the failure of NSF to replace a recently retired division director with someone possessing the requisite good management skills ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies